Torres JDFO, Pereira RS. Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors? World J Gastrointest Pharmacol Ther 2010; 1(5): 102-106 [PMID: 21577303 DOI: 10.4292/wjgpt.v1.i5.102]
Corresponding Author of This Article
Dr. Ricardo de Souza Pereira, Professor, Laboratório de Laser e Microscopia de Força Atômica, Dr. Nivaldo Parizotto, Departamento de Fisioterapia, Universidade Federal de São Carlos, Rod. Washington Luís, São Carlos, SP, Brazil. ricardodesouzapereira@yahoo.com.br
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Pharmacol Ther. Oct 6, 2010; 1(5): 102-106 Published online Oct 6, 2010. doi: 10.4292/wjgpt.v1.i5.102
Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors?
Joanna Dulce Favacho de Oliveira Torres, Ricardo de Souza Pereira
Joanna Dulce Favacho de Oliveira Torres, Universidade Federal do Amapá, Campus Universitário Marco Zero do Equador, Rod. Juscelino Kubitschek, KM-02, Jardim Marco Zero, CEP 68.902-280, Macapá, AP, Brazil
Ricardo de Souza Pereira, Laboratório de Laser e Microscopia de Força Atômica, Dr. Nivaldo Parizotto, Departamento de Fisioterapia, Universidade Federal de São Carlos, Rod. Washington Luís, São Carlos, SP, Brazil
Author contributions: Oliveira-Torres JDF is credited with valuable discussions related to patient biopsy samples, drawing of the structures, acquisition, analysis and interpretation of data (database search work in pubmed and web of science), organization of references and valuable discussions about the questions of referees; Pereira RS is credited with the main idea of chemical structure comparison between omeprazole and melatonin and the possible mechanism of action, writing of the manuscript and answers for the referees.
Supported by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) (Proc. No. 303358/2009-2)
Correspondence to: Dr. Ricardo de Souza Pereira, Professor, Laboratório de Laser e Microscopia de Força Atômica, Dr. Nivaldo Parizotto, Departamento de Fisioterapia, Universidade Federal de São Carlos, Rod. Washington Luís, São Carlos, SP, Brazil. ricardodesouzapereira@yahoo.com.br
Telephone: +55-19-81841411 Fax: +55-19-21177209
Received: April 7, 2010 Revised: September 16, 2010 Accepted: September 23, 2010 Published online: October 6, 2010
Abstract
Melatonin is used in many countries to improve sleep disorders. Melatonin is a hormone produced by the pineal gland and enterochromaffin cells which control sleep and gastrointestinal motility. Low levels of melatonin lead to gastroesophageal reflux disease (GERD). Most of patients with GERD have a sleep disorder. So, low melatonin levels is the main cause of insomnia. Beyond this, it has an inhibitory action on gastric acid secretion and seems to control the lower esophageal sphincter. Proton pump inhibitors (PPIs) are a group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production. They are the most potent inhibitors of acid secretion available today. Omeprazole (one of the PPIs) and melatonin have similarities in their chemical structures. Therefore, we could consider omeprazole as a rough copy of melatonin. In this paper, we compare the advantages and disadvantages of the clinical use of melatonin and PPIs.